ALICE LILLY: Open Payments
NPI 1972067395 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,194 in 121 payments from 24 companies in 2025. Trend: 2023 $489 · 2024 $1,547 · 2025 $2,194
Food & beverage: $2,194
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $353 |
| UCB, Inc. | 12 | $274 |
| Neurelis, Inc. | 7 | $215 |
| Gilead Sciences, Inc. | 17 | $180 |
| Aimmune Therapeutics, Inc. | 9 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $121 |
| Neurocrine BioSciences, Inc. | 5 | $118 |
| Lundbeck LLC | 6 | $112 |
| Janssen Biotech, Inc. | 4 | $108 |
| ARGENX US, INC. | 4 | $70 |
Products named: VALTOCO, ZENPEP, INGREZZA, MAVYRET, Briviact, VYEPTI, LINZESS, TREMFYA.
Industry payments across TN — which companies pay providers there.
